| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:50 UTC |
|---|
| Update Date | 2022-03-07 02:51:43 UTC |
|---|
| HMDB ID | HMDB0014742 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Cisapride |
|---|
| Description | Cisapride, also known as (+-)-cisapride or cisapridum, belongs to the class of organic compounds known as aminobenzamides. These are organic compounds containing a benzamide moiety with an amine group attached to the benzene ring. Cisapride is a drug which is used for the symptomatic treatment of adult patients with nocturnal heartburn due to gastroesophageal reflux disease. Cisapride is a very strong basic compound (based on its pKa). Cisapride is a potentially toxic compound. |
|---|
| Structure | CO[C@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C1=CC(Cl)=C(N)C=C1OC InChI=1S/C23H29ClFN3O4/c1-30-21-13-19(26)18(24)12-17(21)23(29)27-20-8-10-28(14-22(20)31-2)9-3-11-32-16-6-4-15(25)5-7-16/h4-7,12-13,20,22H,3,8-11,14,26H2,1-2H3,(H,27,29)/t20-,22+/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (+-)-Cisapride | ChEBI | | 4-Amino-5-chloro-N-(1-(3-(4-fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide | ChEBI | | 4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide | ChEBI | | cis-4-Amino-5-chloro-N-(1-(3-(p-fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide | ChEBI | | cis-4-Amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide | ChEBI | | cis-4-Amino-5-chloro-N-{1-[3-(p-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide | ChEBI | | Cisaprida | ChEBI | | Cisapridum | ChEBI | | Propulsid | HMDB |
|
|---|
| Chemical Formula | C23H29ClFN3O4 |
|---|
| Average Molecular Weight | 465.945 |
|---|
| Monoisotopic Molecular Weight | 465.183062343 |
|---|
| IUPAC Name | 4-amino-5-chloro-N-[(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-methoxybenzamide |
|---|
| Traditional Name | (+-)-cisapride |
|---|
| CAS Registry Number | 81098-60-4 |
|---|
| SMILES | CO[C@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C1=CC(Cl)=C(N)C=C1OC |
|---|
| InChI Identifier | InChI=1S/C23H29ClFN3O4/c1-30-21-13-19(26)18(24)12-17(21)23(29)27-20-8-10-28(14-22(20)31-2)9-3-11-32-16-6-4-15(25)5-7-16/h4-7,12-13,20,22H,3,8-11,14,26H2,1-2H3,(H,27,29)/t20-,22+/m1/s1 |
|---|
| InChI Key | DCSUBABJRXZOMT-IRLDBZIGSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as aminobenzamides. These are organic compounds containing a benzamide moiety with an amine group attached to the benzene ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Benzoic acids and derivatives |
|---|
| Direct Parent | Aminobenzamides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Aminobenzamide
- Halobenzoic acid or derivatives
- 3-halobenzoic acid or derivatives
- Aminophenyl ether
- Methoxyaniline
- Benzamide
- Phenoxy compound
- Anisole
- Methoxybenzene
- Aniline or substituted anilines
- Benzoyl
- Phenol ether
- Alkyl aryl ether
- Halobenzene
- Fluorobenzene
- Chlorobenzene
- Aryl chloride
- Aryl fluoride
- Aryl halide
- Piperidine
- Amino acid or derivatives
- Tertiary aliphatic amine
- Carboxamide group
- Tertiary amine
- Secondary carboxylic acid amide
- Azacycle
- Organoheterocyclic compound
- Carboxylic acid derivative
- Dialkyl ether
- Ether
- Organic oxygen compound
- Organonitrogen compound
- Organooxygen compound
- Primary amine
- Amine
- Organic nitrogen compound
- Hydrocarbon derivative
- Organofluoride
- Organopnictogen compound
- Organic oxide
- Organochloride
- Organohalogen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 110 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.012 g/L | Not Available | | LogP | 3.3 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 4.96 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 11.0057 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.71 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 58.9 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1375.8 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 190.1 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 188.7 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 183.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 100.0 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 333.0 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 396.3 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 544.3 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 871.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 364.7 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 972.0 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 265.2 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 325.9 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 374.4 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 336.8 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Cisapride,1TMS,isomer #1 | COC1=CC(N[Si](C)(C)C)=C(Cl)C=C1C(=O)N[C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC | 3830.1 | Semi standard non polar | 33892256 | | Cisapride,1TMS,isomer #1 | COC1=CC(N[Si](C)(C)C)=C(Cl)C=C1C(=O)N[C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC | 3389.2 | Standard non polar | 33892256 | | Cisapride,1TMS,isomer #1 | COC1=CC(N[Si](C)(C)C)=C(Cl)C=C1C(=O)N[C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC | 4660.8 | Standard polar | 33892256 | | Cisapride,1TMS,isomer #2 | COC1=CC(N)=C(Cl)C=C1C(=O)N([C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC)[Si](C)(C)C | 3612.0 | Semi standard non polar | 33892256 | | Cisapride,1TMS,isomer #2 | COC1=CC(N)=C(Cl)C=C1C(=O)N([C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC)[Si](C)(C)C | 3312.2 | Standard non polar | 33892256 | | Cisapride,1TMS,isomer #2 | COC1=CC(N)=C(Cl)C=C1C(=O)N([C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC)[Si](C)(C)C | 4933.3 | Standard polar | 33892256 | | Cisapride,2TMS,isomer #1 | COC1=CC(N([Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=C1C(=O)N[C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC | 3670.1 | Semi standard non polar | 33892256 | | Cisapride,2TMS,isomer #1 | COC1=CC(N([Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=C1C(=O)N[C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC | 3358.0 | Standard non polar | 33892256 | | Cisapride,2TMS,isomer #1 | COC1=CC(N([Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=C1C(=O)N[C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC | 4417.8 | Standard polar | 33892256 | | Cisapride,2TMS,isomer #2 | COC1=CC(N[Si](C)(C)C)=C(Cl)C=C1C(=O)N([C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC)[Si](C)(C)C | 3696.5 | Semi standard non polar | 33892256 | | Cisapride,2TMS,isomer #2 | COC1=CC(N[Si](C)(C)C)=C(Cl)C=C1C(=O)N([C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC)[Si](C)(C)C | 3334.5 | Standard non polar | 33892256 | | Cisapride,2TMS,isomer #2 | COC1=CC(N[Si](C)(C)C)=C(Cl)C=C1C(=O)N([C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC)[Si](C)(C)C | 4380.2 | Standard polar | 33892256 | | Cisapride,3TMS,isomer #1 | COC1=CC(N([Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=C1C(=O)N([C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC)[Si](C)(C)C | 3576.3 | Semi standard non polar | 33892256 | | Cisapride,3TMS,isomer #1 | COC1=CC(N([Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=C1C(=O)N([C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC)[Si](C)(C)C | 3250.5 | Standard non polar | 33892256 | | Cisapride,3TMS,isomer #1 | COC1=CC(N([Si](C)(C)C)[Si](C)(C)C)=C(Cl)C=C1C(=O)N([C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC)[Si](C)(C)C | 4109.0 | Standard polar | 33892256 | | Cisapride,1TBDMS,isomer #1 | COC1=CC(N[Si](C)(C)C(C)(C)C)=C(Cl)C=C1C(=O)N[C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC | 4014.2 | Semi standard non polar | 33892256 | | Cisapride,1TBDMS,isomer #1 | COC1=CC(N[Si](C)(C)C(C)(C)C)=C(Cl)C=C1C(=O)N[C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC | 3592.3 | Standard non polar | 33892256 | | Cisapride,1TBDMS,isomer #1 | COC1=CC(N[Si](C)(C)C(C)(C)C)=C(Cl)C=C1C(=O)N[C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC | 4698.1 | Standard polar | 33892256 | | Cisapride,1TBDMS,isomer #2 | COC1=CC(N)=C(Cl)C=C1C(=O)N([C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC)[Si](C)(C)C(C)(C)C | 3805.0 | Semi standard non polar | 33892256 | | Cisapride,1TBDMS,isomer #2 | COC1=CC(N)=C(Cl)C=C1C(=O)N([C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC)[Si](C)(C)C(C)(C)C | 3517.0 | Standard non polar | 33892256 | | Cisapride,1TBDMS,isomer #2 | COC1=CC(N)=C(Cl)C=C1C(=O)N([C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC)[Si](C)(C)C(C)(C)C | 4905.2 | Standard polar | 33892256 | | Cisapride,2TBDMS,isomer #1 | COC1=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(Cl)C=C1C(=O)N[C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC | 4101.4 | Semi standard non polar | 33892256 | | Cisapride,2TBDMS,isomer #1 | COC1=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(Cl)C=C1C(=O)N[C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC | 3768.1 | Standard non polar | 33892256 | | Cisapride,2TBDMS,isomer #1 | COC1=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(Cl)C=C1C(=O)N[C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC | 4464.3 | Standard polar | 33892256 | | Cisapride,2TBDMS,isomer #2 | COC1=CC(N[Si](C)(C)C(C)(C)C)=C(Cl)C=C1C(=O)N([C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC)[Si](C)(C)C(C)(C)C | 4039.9 | Semi standard non polar | 33892256 | | Cisapride,2TBDMS,isomer #2 | COC1=CC(N[Si](C)(C)C(C)(C)C)=C(Cl)C=C1C(=O)N([C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC)[Si](C)(C)C(C)(C)C | 3696.4 | Standard non polar | 33892256 | | Cisapride,2TBDMS,isomer #2 | COC1=CC(N[Si](C)(C)C(C)(C)C)=C(Cl)C=C1C(=O)N([C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC)[Si](C)(C)C(C)(C)C | 4463.5 | Standard polar | 33892256 | | Cisapride,3TBDMS,isomer #1 | COC1=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(Cl)C=C1C(=O)N([C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC)[Si](C)(C)C(C)(C)C | 4155.2 | Semi standard non polar | 33892256 | | Cisapride,3TBDMS,isomer #1 | COC1=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(Cl)C=C1C(=O)N([C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC)[Si](C)(C)C(C)(C)C | 3833.8 | Standard non polar | 33892256 | | Cisapride,3TBDMS,isomer #1 | COC1=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C(Cl)C=C1C(=O)N([C@@H]1CCN(CCCOC2=CC=C(F)C=C2)C[C@@H]1OC)[Si](C)(C)C(C)(C)C | 4220.3 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Cisapride GC-MS (Non-derivatized) - 70eV, Positive | splash10-001i-2922000000-0772f474daac82b426ee | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Cisapride GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Cisapride GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Cisapride LC-ESI-qTof , Positive-QTOF | splash10-001i-0980000000-a0df861122e90da3494b | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cisapride , positive-QTOF | splash10-001i-0980000000-a0df861122e90da3494b | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cisapride , positive-QTOF | splash10-0159-0710900000-262b97df953edaab4cfa | 2017-09-14 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cisapride 10V, Positive-QTOF | splash10-0159-0111900000-61265dea2a01bd8e8378 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cisapride 20V, Positive-QTOF | splash10-001i-0943300000-cdcfabdf19797140d795 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cisapride 40V, Positive-QTOF | splash10-0006-9861100000-46b94051a1f1227c9363 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cisapride 10V, Negative-QTOF | splash10-03di-0400900000-c6cda5b55f88160e99de | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cisapride 20V, Negative-QTOF | splash10-03di-0921500000-6011948830548e90b8dc | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cisapride 40V, Negative-QTOF | splash10-03di-2910000000-5144f15cb7a70d64b8a3 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cisapride 10V, Positive-QTOF | splash10-014i-0001900000-8df7d19bd80f8e92fe73 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cisapride 20V, Positive-QTOF | splash10-0gb9-0439600000-d40cbd486ff327890e07 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cisapride 40V, Positive-QTOF | splash10-03ea-4902100000-c20a14020bf3f34d23dd | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cisapride 10V, Negative-QTOF | splash10-03di-0100900000-10eb08fa13f12fb9bc9d | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cisapride 20V, Negative-QTOF | splash10-03di-5915600000-de23551ac41099e763f9 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cisapride 40V, Negative-QTOF | splash10-0il0-9411000000-a20e7213ffcaf2d0f91f | 2021-10-11 | Wishart Lab | View Spectrum |
|
|---|